Chemically Induced Platelet Lysis Causes Vasoconstriction by Release of Serotonin

This publication has 35 references indexed in Scilit:

• Metabolism and Cytotoxicity of Menadione and Its Metabolite in Rat Platelets
  Toxicology and Applied Pharmacology, 1997
• Low-dose aspirin inhibits platelet-induced contraction of the human isolated coronary artery. A role for additional 5-hydroxytryptamine receptor antagonism against coronary vasospasm?
  Circulation, 1994
• Interaction between thromboxane A2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries.
  Circulation, 1993
• 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries
  Cardiovascular Research, 1990
• Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses.
  Circulation, 1987
• Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries.
  Circulation, 1986
• Platelet-mediated vascular permeability in the rat: A predominant role for 5-hydroxytryptamine
  Thrombosis Research, 1985
• Platelet-mediated vascular contractions: Inhibition of the serotonergic component by ketanserin
  Thrombosis Research, 1982
• COMPARISON OF THE ACTIONS OF U‐46619, A PROSTAGLANDIN H₂‐ANALOGUE, WITH THOSE OF PROSTAGLANDIN H₂ AND THROMBOXANE A₂ ON SOME ISOLATED SMOOTH MUSCLE PREPARATIONS
  British Journal of Pharmacology, 1981
• Coronary Arterial Smooth Muscle Contraction by a Substance Released from Platelets: Evidence That It Is Thromboxane A ₂
  Science, 1976